PL376048A1 - Podstawione pochodne 1-piperydyn-4-ylo-4-pirolidyn-3-ylopiperazyny i ich zastosowanie jako antagonistów neurokininy - Google Patents

Podstawione pochodne 1-piperydyn-4-ylo-4-pirolidyn-3-ylopiperazyny i ich zastosowanie jako antagonistów neurokininy

Info

Publication number
PL376048A1
PL376048A1 PL03376048A PL37604803A PL376048A1 PL 376048 A1 PL376048 A1 PL 376048A1 PL 03376048 A PL03376048 A PL 03376048A PL 37604803 A PL37604803 A PL 37604803A PL 376048 A1 PL376048 A1 PL 376048A1
Authority
PL
Poland
Prior art keywords
pyrrolidin
piperidin
substituted
piperazine derivatives
neurokinin antagonists
Prior art date
Application number
PL03376048A
Other languages
English (en)
Inventor
Frans Eduard Janssens
François Maria Sommen
Boeck Benoit Christian Albert Ghislain De
Joseph Elisabeth Leenaerts
Original Assignee
Janssen Pharmaceutica N.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica N.V. filed Critical Janssen Pharmaceutica N.V.
Publication of PL376048A1 publication Critical patent/PL376048A1/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Pulmonology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
PL03376048A 2002-12-23 2003-12-17 Podstawione pochodne 1-piperydyn-4-ylo-4-pirolidyn-3-ylopiperazyny i ich zastosowanie jako antagonistów neurokininy PL376048A1 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP0214831 2002-12-23

Publications (1)

Publication Number Publication Date
PL376048A1 true PL376048A1 (pl) 2005-12-12

Family

ID=32668698

Family Applications (1)

Application Number Title Priority Date Filing Date
PL03376048A PL376048A1 (pl) 2002-12-23 2003-12-17 Podstawione pochodne 1-piperydyn-4-ylo-4-pirolidyn-3-ylopiperazyny i ich zastosowanie jako antagonistów neurokininy

Country Status (30)

Country Link
US (1) US7795261B2 (pl)
EP (1) EP1581518B1 (pl)
JP (1) JP4746878B2 (pl)
KR (1) KR101049073B1 (pl)
CN (1) CN100586945C (pl)
AR (1) AR042651A1 (pl)
AT (1) ATE500242T1 (pl)
AU (1) AU2003302488B2 (pl)
BR (1) BR0317658A (pl)
CA (1) CA2508657C (pl)
CL (1) CL2003002725A1 (pl)
CY (1) CY1112601T1 (pl)
DE (1) DE60336266D1 (pl)
DK (1) DK1581518T3 (pl)
EA (1) EA009078B1 (pl)
ES (1) ES2361161T3 (pl)
HR (1) HRP20050556B1 (pl)
IL (1) IL169336A (pl)
JO (1) JO2696B1 (pl)
MX (1) MXPA05006887A (pl)
MY (1) MY145135A (pl)
NO (1) NO331174B1 (pl)
NZ (1) NZ541035A (pl)
PA (1) PA8593301A1 (pl)
PL (1) PL376048A1 (pl)
PT (1) PT1581518E (pl)
SI (1) SI1581518T1 (pl)
TW (1) TWI329109B (pl)
UA (1) UA80584C2 (pl)
WO (1) WO2004056799A2 (pl)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2847160A1 (fr) * 2002-11-20 2004-05-21 Oreal Composition capillaire contenant un compose pyrasol-carboxamide, son utilisation pour stimuler la pousse des cheveux et/ou freiner leur chute
ES2431524T3 (es) 2004-04-13 2013-11-26 Incyte Corporation Derivados de piperazinilpiperidina como antagonistas de los receptores de quimiocinas
WO2005123081A2 (en) * 2004-06-22 2005-12-29 Janssen Pharmaceutica N.V. (2-benzyl-4-{4-[1-(tetrahydrofuran-3-carbonyl)-pyrrolidin-3-yl]-piperazin-1-yl}-piperidin-1-yl)-(3,5-trifluoromethyl-phenyl))-methanone for the treatment of schizophrenia
US7635698B2 (en) 2004-12-29 2009-12-22 Millennium Pharmaceuticals, Inc. Compounds useful as chemokine receptor antagonists
WO2006071875A1 (en) * 2004-12-29 2006-07-06 Millennium Pharmaceuticals, Inc. Compounds useful as chemokine receptor antagonists
NZ556628A (en) 2005-03-08 2009-09-25 Janssen Pharmaceutica Nv Diaza-spiro-[4.4]-nonane derivatives as neurokinin (NK1) antagonists
DE102005038947A1 (de) * 2005-05-18 2006-11-30 Grünenthal GmbH Substituierte Benzo[d]isoxazol-3-yl-amin-Verbindungen und deren Verwendung in Arzneimitteln
MX2009005252A (es) * 2006-11-17 2009-05-28 Abbott Lab Aminopirrolidinas como antagonistas del receptor de quimiocina.
AU2008234880B2 (en) * 2007-03-31 2011-10-20 Intervet International B.V. Processes for making zilpaterol and salts thereof
RU2442786C2 (ru) * 2007-03-31 2012-02-20 Интервет Интернэшнл Б.В. Способы получения зилпатерола и его солей
MX2009010499A (es) 2007-03-31 2009-10-19 Intervet Int Bv Procesos para elaborar zilpaterol y sales del mismo.
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
WO2008151257A2 (en) 2007-06-04 2008-12-11 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
DE602008003221D1 (de) 2007-06-07 2010-12-09 Hoffmann La Roche Prolinamidderivate als nk3-antagonisten
ES2624828T3 (es) 2008-07-16 2017-07-17 Synergy Pharmaceuticals Inc. Agonistas de la guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros
US8507535B2 (en) * 2010-07-07 2013-08-13 Hoffmann-La Roche Inc. Methyl-pyrrolidine ether derivatives
KR20150046259A (ko) * 2012-08-23 2015-04-29 앨리오스 바이오파마 인크. 파라믹소바이러스 바이러스성 감염의 치료용 화합물
US9708367B2 (en) 2013-03-15 2017-07-18 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase and their uses
EP2968439A2 (en) 2013-03-15 2016-01-20 Synergy Pharmaceuticals Inc. Compositions useful for the treatment of gastrointestinal disorders
AU2016264034B2 (en) 2015-05-18 2020-03-05 KaNDy Therapeutics Limited Dual NK-1/NK-3 receptor antagonists for the treatment of sex-hormone-dependent diseases
EA202092131A1 (ru) 2018-03-14 2020-11-27 Кэнди Терапьютикс Лимитед Новый фармацевтический препарат, содержащий двойные антагонисты рецептора nk-1/nk-3
AU2019387370A1 (en) 2018-11-30 2021-06-10 Nuvation Bio Inc. Pyrrole and pyrazole compounds and methods of use thereof
US12533358B1 (en) 2025-05-14 2026-01-27 Bayer Consumer Care Ag Methods of treatment with elinzanetant

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY110227A (en) 1991-08-12 1998-03-31 Ciba Geigy Ag 1-acylpiperindine compounds.
US5589489A (en) * 1993-12-15 1996-12-31 Zeneca Limited Cyclic amide derivatives for treating asthma
NZ321575A (en) * 1995-10-30 1999-05-28 Janssen Pharmaceutica Nv 1-(1,2-disubstituted piperidinyl)-4- substituted piperazine derivatives
TW382017B (en) 1995-12-27 2000-02-11 Janssen Pharmaceutica Nv 1-(1,2-disubstituted piperidinyl)-4-(fused imidazole)-piperidine derivatives
AU7788500A (en) 1999-10-25 2001-05-08 Janssen Pharmaceutica N.V. Use of substance p antagonists for influencing the circadian timing system
GB0025354D0 (en) * 2000-10-17 2000-11-29 Glaxo Group Ltd Chemical compounds
US6642226B2 (en) 2001-02-06 2003-11-04 Hoffman-La Roche Inc. Substituted phenyl-piperidine methanone compounds
FR2820426B1 (fr) * 2001-02-07 2007-05-11 Condat Sa Gel d'isolation thermique a reticulation controlee pour les lignes de transport d'hydrocarbures petroliers
MY141736A (en) 2002-10-08 2010-06-15 Elanco Animal Health Ireland Substituted 1,4-di-piperidin-4-yi-piperazine derivatives and their use as neurokinin antagonists

Also Published As

Publication number Publication date
US7795261B2 (en) 2010-09-14
NO20053569L (no) 2005-09-15
CY1112601T1 (el) 2016-02-10
KR101049073B1 (ko) 2011-07-15
TWI329109B (en) 2010-08-21
HK1087703A1 (zh) 2006-10-20
UA80584C2 (uk) 2007-10-10
NO331174B1 (no) 2011-10-24
JO2696B1 (en) 2013-03-03
HRP20050556B1 (hr) 2014-03-28
JP2006514027A (ja) 2006-04-27
AU2003302488A1 (en) 2004-07-14
PT1581518E (pt) 2011-05-12
US20060040950A1 (en) 2006-02-23
DE60336266D1 (de) 2011-04-14
NZ541035A (en) 2008-05-30
WO2004056799A2 (en) 2004-07-08
WO2004056799A3 (en) 2004-08-12
KR20050085098A (ko) 2005-08-29
MY145135A (en) 2011-12-30
ES2361161T3 (es) 2011-06-14
NO20053569D0 (no) 2005-07-21
CA2508657A1 (en) 2004-07-08
EP1581518A2 (en) 2005-10-05
AU2003302488B2 (en) 2009-10-08
JP4746878B2 (ja) 2011-08-10
CL2003002725A1 (es) 2005-04-08
ATE500242T1 (de) 2011-03-15
HRP20050556A2 (en) 2006-07-31
CA2508657C (en) 2013-02-19
BR0317658A (pt) 2005-12-06
SI1581518T1 (sl) 2011-06-30
IL169336A0 (en) 2007-07-04
IL169336A (en) 2013-01-31
EA200501041A1 (ru) 2005-12-29
EP1581518B1 (en) 2011-03-02
PA8593301A1 (es) 2004-08-31
DK1581518T3 (da) 2011-06-06
EA009078B1 (ru) 2007-10-26
MXPA05006887A (es) 2005-08-16
AR042651A1 (es) 2005-06-29
TW200500359A (en) 2005-01-01
CN1726207A (zh) 2006-01-25
CN100586945C (zh) 2010-02-03

Similar Documents

Publication Publication Date Title
IL169336A0 (en) Substituted 1-piperidin-4-yl-4-pyrrolidin-3-yl-piperazine derivatives and their use as neurokinin antagonists
AU2003259267A8 (en) Substituted aminopyrimidines as neurokinin antagonists
IL189658A0 (en) N-phenyl-2-pyrimidine-amine derivatives
IL165841A0 (en) Mchir antagonists
HUP0500871A3 (en) 5-aryltetrazole compounds, compositions thereof and their use
IL178461A0 (en) Substituted 4-alkyl -and 4-alkanoyl-piperidine derivatives and their use as neurokinin antagonists
GB0220214D0 (en) Compounds and their use
AU2003277215A8 (en) Novel neurokinin antagonists and methods of use thereof
IL174497A0 (en) Pyridine derivatives and use thereof as urotensin ii antagonists
IL166821A0 (en) Novel 1,4-diazabicycloalkane derivatives their preparation and use
AU2003279841A8 (en) Uses of human zven antagonists
AU2003207023A1 (en) Piperidine derivatives and their use as antagonists of tachykinins
PL1641787T3 (pl) Podstawione diketopiperazyny i ich zastosowanie jako antagonistów oksytocyny
PL376843A1 (pl) Podstawione pirydyloksyalkiloamidy i ich zastosowanie jako fungicydów
PL370221A1 (pl) 2-Oksazoloaminy oraz zastosowanie ich jako antagonistów receptora 5-HT2B
IL169337A0 (en) Substituted 1-piperidin-3-yl-4-piperidin-4-yl-piperazine derivatives and their use as neurokinin antagonists
AU2002368487A1 (en) Substituted 1,4-di-piperidin-4-yl-piperazine derivatives and their use as tachykinin antagonists
PL377711A1 (pl) Pochodne karboksyamidowe i ich zastosowanie jako inhibitorów czynnika Xa
AU2003303068A1 (en) Carbazole derivatives and their use as npy-5 antagonists
IL162534A0 (en) Novel alkansulfonamides as endotheline antagonists
GB0227906D0 (en) Compounds and their use
PL376403A1 (pl) Pochodne podstawionej 1,4-di(piperydyn-4-ylo)piperazyny oraz ich zastosowanie jako antagonistów neurokinin
GB0307231D0 (en) 7-Nitroindoline derivatives and their uses
SI1641787T1 (sl) Substituirani diketopiperazini in njihova uporabakot oksitocinski antagonisti
GB0218031D0 (en) Compounds and their use

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)